1733 — Apex Biotechnology Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedSmall CapNeutral

Annual balance sheet for Apex Biotechnology, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	631	398	444	605	644
Net Total Accounts Receivable
Net Total Receivables	488	497	294	355	448
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	1,760	1,654	1,507	1,643	1,674
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	799	771	723	703	656
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	2,670	2,515	2,297	2,420	2,416
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	786	571	383	478	432
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	918	697	501	596	546
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	1,753	1,817	1,796	1,824	1,870
Total Liabilities & Shareholders' Equity	2,670	2,515	2,297	2,420	2,416
Total Common Shares Outstanding